lobbying_activities: 2954108

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2954108	4e95d65d-1534-428a-ab9f-9bfbf02629c3	1T	TIBER CREEK GROUP	20744	MCDERMOTT WILL & EMERY LLP (OBO ALNYLAM PHARMACEUTICALS)	2023	first_quarter	MMM	Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169).	HOUSE OF REPRESENTATIVES,SENATE	40000		0	1	2023-03-10T09:42:48-05:00